Drug Shortage Report for MYLAN-VALSARTAN
Report ID | 9049 |
Drug Identification Number | 02383551 |
Brand name | MYLAN-VALSARTAN |
Common or Proper name | VALSARTAN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VALSARTAN |
Strength(s) | 320MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | discontinued in ID 20217 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.